secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001493152-23-004392
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aesther Healthcare amends backstop agreement; increases share purchase limit to 8M, defers $4.37M in expenses
--------------------------------------------------------------------------------

- Amended backstop agreement with Vellar increases maximum shares Vellar may purchase from 6,000,000 to 8,000,000.
- Vendors have deferred approximately $4,374,646 in transaction expenses.
- Agreement is in connection with proposed merger with Ocean Biomedical (previously announced on Aug 31, 2022).
- Break-up fee of $1,000,000 plus legal fees payable to Vellar under certain termination events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223004392/0001493152-23-004392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223004392/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer